4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS
PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs...
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | LAN, NANCY, C CAI, SUI, XIONG ZHOU, ZHANG-LIN WEBER, ECKARD YEUN, PO-WAI KEANA, JOHN, F., W BIGGE, CHRISTOPHER, F WOODWARD, RICHARD GUZIKOWSKI, ANTHONY, P |
description | PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP0869792B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP0869792B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP0869792B13</originalsourceid><addsrcrecordid>eNqNi0sKwjAQQLNxIeod5gIFf2i7TJuxHahJyEwFF1KKxJVood4fs_AArh483pur2z7jrmQh6QQNePIYyJBF0Fa3ruZEA9IgBeg4WYbUy9UjMLZYCV0Q7NloCFihFxfSILp2llh4qWaP4TnF1Y8LBSeUqsni-O7jNA73-IqfHv06PxTHYltudn8kX5jZMn4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>LAN, NANCY, C ; CAI, SUI, XIONG ; ZHOU, ZHANG-LIN ; WEBER, ECKARD ; YEUN, PO-WAI ; KEANA, JOHN, F., W ; BIGGE, CHRISTOPHER, F ; WOODWARD, RICHARD ; GUZIKOWSKI, ANTHONY, P</creator><creatorcontrib>LAN, NANCY, C ; CAI, SUI, XIONG ; ZHOU, ZHANG-LIN ; WEBER, ECKARD ; YEUN, PO-WAI ; KEANA, JOHN, F., W ; BIGGE, CHRISTOPHER, F ; WOODWARD, RICHARD ; GUZIKOWSKI, ANTHONY, P</creatorcontrib><description>PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.</description><edition>7</edition><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050309&DB=EPODOC&CC=EP&NR=0869792B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050309&DB=EPODOC&CC=EP&NR=0869792B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LAN, NANCY, C</creatorcontrib><creatorcontrib>CAI, SUI, XIONG</creatorcontrib><creatorcontrib>ZHOU, ZHANG-LIN</creatorcontrib><creatorcontrib>WEBER, ECKARD</creatorcontrib><creatorcontrib>YEUN, PO-WAI</creatorcontrib><creatorcontrib>KEANA, JOHN, F., W</creatorcontrib><creatorcontrib>BIGGE, CHRISTOPHER, F</creatorcontrib><creatorcontrib>WOODWARD, RICHARD</creatorcontrib><creatorcontrib>GUZIKOWSKI, ANTHONY, P</creatorcontrib><title>4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS</title><description>PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNi0sKwjAQQLNxIeod5gIFf2i7TJuxHahJyEwFF1KKxJVood4fs_AArh483pur2z7jrmQh6QQNePIYyJBF0Fa3ruZEA9IgBeg4WYbUy9UjMLZYCV0Q7NloCFihFxfSILp2llh4qWaP4TnF1Y8LBSeUqsni-O7jNA73-IqfHv06PxTHYltudn8kX5jZMn4</recordid><startdate>20050309</startdate><enddate>20050309</enddate><creator>LAN, NANCY, C</creator><creator>CAI, SUI, XIONG</creator><creator>ZHOU, ZHANG-LIN</creator><creator>WEBER, ECKARD</creator><creator>YEUN, PO-WAI</creator><creator>KEANA, JOHN, F., W</creator><creator>BIGGE, CHRISTOPHER, F</creator><creator>WOODWARD, RICHARD</creator><creator>GUZIKOWSKI, ANTHONY, P</creator><scope>EVB</scope></search><sort><creationdate>20050309</creationdate><title>4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS</title><author>LAN, NANCY, C ; CAI, SUI, XIONG ; ZHOU, ZHANG-LIN ; WEBER, ECKARD ; YEUN, PO-WAI ; KEANA, JOHN, F., W ; BIGGE, CHRISTOPHER, F ; WOODWARD, RICHARD ; GUZIKOWSKI, ANTHONY, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP0869792B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2005</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>LAN, NANCY, C</creatorcontrib><creatorcontrib>CAI, SUI, XIONG</creatorcontrib><creatorcontrib>ZHOU, ZHANG-LIN</creatorcontrib><creatorcontrib>WEBER, ECKARD</creatorcontrib><creatorcontrib>YEUN, PO-WAI</creatorcontrib><creatorcontrib>KEANA, JOHN, F., W</creatorcontrib><creatorcontrib>BIGGE, CHRISTOPHER, F</creatorcontrib><creatorcontrib>WOODWARD, RICHARD</creatorcontrib><creatorcontrib>GUZIKOWSKI, ANTHONY, P</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LAN, NANCY, C</au><au>CAI, SUI, XIONG</au><au>ZHOU, ZHANG-LIN</au><au>WEBER, ECKARD</au><au>YEUN, PO-WAI</au><au>KEANA, JOHN, F., W</au><au>BIGGE, CHRISTOPHER, F</au><au>WOODWARD, RICHARD</au><au>GUZIKOWSKI, ANTHONY, P</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS</title><date>2005-03-09</date><risdate>2005</risdate><abstract>PCT No. PCT/US96/20872 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23216 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs are selective active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, psychosis, anxiety, migraine headaches, glaucoma, CMV retinitis, aminoglycoside antibiotics-induced hearing loss, convulsions, chronic pain, opioid tolerance or withdrawal, urinary incontinence or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre ; ger |
recordid | cdi_epo_espacenet_EP0869792B1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
title | 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A33%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LAN,%20NANCY,%20C&rft.date=2005-03-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP0869792B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |